IP Library Granted Patent US 11,812,965
Granted Patent B2
US 11,812,965 · App. 16/434,317 · Granted Nov 14, 2023

Layer of material for a surgical end effector

Inventors: Chester O. Baxter, III (Loveland, OH); Frederick E. Shelton, IV (Hillsboro, OH); Charles J. Scheib (Loveland, OH); Christopher W. Widenhouse (Clarksville, OH); William B. Weisenburgh, II (Maineville, OH); John L. Stammen (Cincinnati, OH); Mark H. Ransick (West Chester, OH); Stephanie A. Mutchler (Loveland, OH); Gary W. Knight (West Chester, OH); Michael S. Cropper (Edgewood, KY); Sean P. Conlon (Loveland, OH); Jeffrey S. Swayze (West Chester, OH)
Assignee: Cilag GmbH International
A61B17/07292A61B17/00491A61B17/068A61B17/072A61B17/07207A61B17/1155A61L17/005A61B17/0644A61B17/2909A61B2017/00004A61B2017/0053A61B2017/00477A61B2017/00526A61B2017/00561A61B2017/00818A61B2017/00862A61B2017/00884A61B2017/00889A61B2017/00893A61B2017/00898A61B2017/00942A61B2017/00951A61B2017/07228A61B2017/07235A61B2017/07242A61B2017/07264A61B2017/07271A61B2017/07278A61B2017/07285A61B2017/2908A61B2017/2919A61B2017/2923A61B2017/2927A61B2017/2933A61B2017/2936A61B2017/2946A61B2017/320052A61B2090/0811A61B2090/3966A61L2300/102A61L2300/232A61L2300/45F04C2270/0421Y10T29/49826
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,812,965
App. No.
16/434,317
Granted
Nov 14, 2023
Kind
B2
Abstract

A staple cartridge assembly comprising a tissue thickness compensator is disclosed. The tissue thickness compensator comprises a first fibrous, woven material and a second fibrous, woven material. The first fibrous, woven material comprises a density which is different than the density of the second fibrous, woven material. The tissue thickness compensator is configured to expand upon contact with a fluid in order to apply a compressive force to tissue captured within staples.

Claims (38)

1. A staple cartridge assembly, comprising:

a staple cartridge, comprising:

a cartridge deck;

staple cavities; and

a plurality of staples stored in said staple cavities, wherein said staples are deformable to a formed height during a progressive firing motion;

a tissue thickness compensator positionable on said cartridge deck, comprising:

a first fibrous, woven material; and

a second fibrous, woven material, wherein said second fibrous, woven material is different than said first fibrous, woven material, wherein said first fibrous, woven material comprises a first density and said second fibrous, woven material comprises a second density which is different than said first density, wherein said tissue thickness compensator is configured to expand upon contact with a fluid in order to apply a compressive force to tissue captured within said staples as a result of said progressive firing motion, wherein said first fibrous, woven material and said second fibrous, woven material each comprise a haemostatic agent, and wherein said haemostatic agents are configured to interact with one another in order to induce a biological response in tissue captured within said staples, wherein said tissue thickness compensator comprises an initial height before said tissue thickness compensator is captured within said staples, wherein said initial height is greater than said formed height of said staples.

2. The staple cartridge assembly of claim 1 , wherein said first fibrous, woven material is more hydrophilic than said second fibrous, woven material.

3. The staple cartridge assembly of claim 1 , wherein said first fibrous, woven material is denser than said second fibrous, woven material.

4. The staple cartridge assembly of claim 1 , wherein said first fibrous, woven material comprises an exterior layer of said tissue thickness compensator.

5. The staple cartridge assembly of claim 4 , wherein said second fibrous, woven material comprises an interior layer of said tissue thickness compensator.

6. The staple cartridge assembly of claim 1 , wherein the fluid comprises water, saline, or a bodily fluid.

7. A staple cartridge assembly, comprising:

a staple cartridge, comprising:

a cartridge deck;

staple cavities; and

a plurality of staples stored in said staple cavities, wherein said staples are deformable to a formed height during a progressive firing motion;

an implantable adjunct capable of being positioned on said cartridge deck, comprising:

a first woven construct; and

a second woven construct, wherein said second woven construct is different than said first woven construct, wherein said first woven construct comprises a first density and said second woven construct comprises a second density different than said first density, wherein said implantable adjunct is configured to expand upon contact with a fluid in order to adapt to a thickness of tissue captured within said staples due to said progressive firing motion, wherein said first woven construct and said second woven construct each comprise a different haemostatic agent, and wherein said different haemostatic agents are configured to interact with one another in order to induce a biological response in tissue captured within said staples, wherein said implantable adjunct comprises a first height, wherein said first height is greater than said formed height of said staples.

8. The staple cartridge assembly of claim 7 , wherein said first woven construct is more hydrophilic than said second woven construct.

9. The staple cartridge assembly of claim 7 , wherein said first woven construct is denser than said second woven construct.

10. The staple cartridge assembly of claim 7 , wherein said first woven construct comprises an exterior layer of said implantable adjunct.

11. The staple cartridge assembly of claim 10 , wherein said second woven construct comprises an interior layer of said implantable adjunct.

12. The staple cartridge assembly of claim 7 , wherein the fluid comprises water, saline, or a bodily fluid.

13. A staple cartridge, comprising:

a cartridge deck;

staple cavities;

a plurality of staples stored in said staple cavities, wherein said staples are deformable to a formed height during a progressive firing motion; and

an implantable layer positionable on said cartridge deck, comprising:

a first woven, fiber construct; and

a second woven, fiber construct, wherein said second woven, fiber construct is different than said first woven, fiber construct, wherein said first woven, fiber construct comprises a first density and said second woven, fiber construct comprises a second density which is different than said first density, wherein said implantable layer is configured to expand upon contact with a fluid in order to apply a compressive force to tissue captured within said staples as a result of said progressive firing motion, wherein said first woven, fiber construct and said second woven, fiber construct each comprise differing haemostatic agents, and wherein said differing haemostatic agents are configured to react to one another and induce a biological response in tissue captured within said staples, wherein said implantable layer comprises a first height, wherein said first height is greater than said formed height of said staples.

14. The staple cartridge of claim 13 , wherein said first woven, fiber construct is more hydrophilic than said second woven, fiber construct.

15. The staple cartridge of claim 13 , wherein said first woven, fiber construct is denser than said second woven, fiber construct.

16. The staple cartridge of claim 13 , wherein said first woven, fiber construct comprises an exterior layer of said implantable layer.

17. The staple cartridge of claim 16 , wherein said second woven, fiber construct comprises an interior layer of said implantable layer.

18. The staple cartridge of claim 13 , wherein the fluid comprises water, saline, or a bodily fluid.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2021
From: ETHICON LLC
To: CILAG GMBH INTERNATIONAL
Reel/Frame 056601/0339 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2019
From: BAXTER, CHESTER O., III; SHELTON, FREDERICK E., IV; SCHEIB, CHARLES J.; WIDENHOUSE, CHRISTOPHER W.; WEISENBURGH, WILLIAM B., II; STAMMEN, JOHN L.; RANSICK, MARK H.; MUTCHLER, STEPHANIE A.; KNIGHT, GARY W.; CROPPER, MICHAEL S.; CONLON, SEAN P.; SWAYZE, JEFFREY S.
To: ETHICON LLC
Reel/Frame 051380/0067 →
Continuity (7)
Continuation In Part 15800713 · Nov 1, 2017
Continuation 13766325 · Feb 13, 2013
Continuation 13433129 · Mar 28, 2012
Continuation 13433141 · Mar 28, 2012
Continuation In Part 13097891 · Apr 29, 2011
Continuation In Part 12894377 · Sep 30, 2010
Related Publication 20190290267A1 · Sep 26, 2019
Cited By (4)
US 12,213,671 US 12,408,914 US 12,440,208 US 12,446,877